Please login to the form below
Eli Lilly
This page shows the latest Eli Lilly news and features for those working in and with pharma, biotech and healthcare.
Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
Trial included patients with pancreatic, colon, breast and salivary cancer. Eli Lilly has revealed new early-stage data for its RET inhibitor Retevmo in new cancer types, as the company looks ... According to Lilly, responses were ongoing in 73% of
Latest news
-
Pfizer launches early study of COVID-19 antiviral therapeutic
With its antiviral candidates, Pfizer is now aiming to enter the COVID-19 therapeutic space, where Regeneron and Eli Lilly have largely dominated so far. ... Lilly’s monoclonal antibody (mAb) bamlanivimab has been given an EUA for the treatment of
-
Lilly reports positive data from its phase 3 ulcerative colitis trial
Eli Lilly’s IL-23 blocker mirikizumab has hit the mark in a phase 3 study in ulcerative colitis (UC), helping patients to achieve clinical remission 12 weeks after initiating treatment. ... inflammation. In addition, Lilly’s drug led to an
-
Lilly to expand donanemab study in a bid for approval in Alzheimer’s disease
Eli Lilly has revealed expanded findings from a phase 2 trial of its potential Alzheimer’s disease treatment donanemab, and announced plans to expand the clinical programme for the drug in ... Donanemab has the potential to become a very important
-
EMA starts rolling review of Lilly’s COVID-19 antibodies
The European Medicines Agency (EMA) has announced that its Committee for Medicinal Products for Human Use (CHMP) has launched a rolling review for Eli Lilly’s COVID-19 antibodies bamlanivimab and ... Earlier this week, the EMA issued advice
-
Researchers use AI to identify drugs that could be repurposed for Alzheimer’s
Eli Lilly's JAK inhibitor Olumiant identified as a potential treatment for repurposing. ... One of the drugs identified using the DRIAD method was Eli Lilly’s Olumiant(baricitinib), which will be investigated in a clinical trial for patients with
More from news
Approximately 136 fully matching, plus 632 partially matching documents found.
Latest Intelligence
-
Switzerland: a life sciences hub
The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.
-
AI: the smart money is on the smart thinking
Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
-
The impact of COVID-19 on clinical trials
Eli Lilly, Bristol-Myers Squibb and Pfizer also have multiple development programmes that are paused or delayed.
-
Working together against COVID-19
A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli Lilly, J&J, Merck, Novartis, Pfizer and Sanofi.
-
COVID-19: the race to find a vaccine
A pack of other antibody programmes involving companies including Amgen, AstraZeneca, Eli Lilly and GlaxoSmithKline is following closely behind, with multiple clinical trials scheduled to start over the summer.
More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.
Latest appointments
-
Eli Lilly promotes Anat Ashkenazi to chief financial officer
Ashkenazi previously served as CFO of Lilly Research Laboratories. Eli Lilly has appointed Anat Ashkenazi (pictured above) as chief financial officer (CFO) and senior vice president of the company. ... Most recently, Ashkenazi served as senior vice
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
Prior to J&J, Torres worked for 14 years at Eli Lilly in a range of commercial roles, including leading US women’s health, global neuroscience and growth hormone.
-
New hires at bluebird bio, BioNTech and Provention Bio
At the start of her career, she worked at Eli Lilly across various roles.
-
New hires at FibroGen, Saniona and Turbine
Eli Lilly and president of Lilly Diabetes and USA. ... Conterno joined Eli Lilly in 1992, and went on to spend two decades working at the company, both in the US and internationally.
-
New hires at Amgen, Eli Lilly and Zosano
Eli Lilly. Mike Mason is set to take on the role of senior vice president of Lilly and president of Lilly Diabetes and Lilly USA. ... Conterno has spent 27 years at Lilly, and spent decades working across sales, marketing, finance, business development
More from appointments
Approximately 7 fully matching, plus 33 partially matching documents found.
Latest from PMHub
-
Three strategies for managing loss of exclusivity successfully
5. Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. ... Eli Lilly’s messaging focussed on the potential negative impact on adherence should their prescribed treatment change.
-
Three is the magic number
Manahil Afseh promoted to Senior Account Executive Manahil joined Aurora nine months ago as an Account Executive after completing a year as a marketing associate at Eli Lilly.
-
Three strategies for managing loss of exclusivity successfully
Eli Lilly’s messaging focussed on the potential negative impact on adherence should their prescribed treatment change. ... However, 2019 saw Eli Lilly respond to criticism of high insulin prices by launching a cut-price version.
-
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
Matthias Heurich also brings a wealth of Pharma market research expertise, having previously worked client-side as a market research consultant at Eli Lilly.
-
Webcast: Navigating new frontiers: Ways to find space in the future RA market
In partnership with pharmaphorum. Although there are only two drugs in this class available in the region – Eli Lilly’s Olumiant (baricitinib) and Pfizer’s Xeljanz (tofacitinib) – this is not likely
More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Virtual congresses: video thrilled the cardio tsar
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- US pauses rollout of J&J’s COVID-19 vaccine amid reports of rare blood clots
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- FDA approves new self-injection administration for Xolair
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
Quick links
Infographics
